The development of biological drugs such as gene and cell therapies and vaccines is boosting the production of pharmaceutical injectables in the global healthcare market.
Recommended Buyer's Guides
Chronic illnesses, an ageing population, and faster approval of sterile injectables compared to other drug types are some of the factors responsible for the increase in demand for pharmaceutical injectables.
Pharmaceutical companies are turning to injectables pharmaceutical companies in contract manufacturing to meet this growing demand.
Generic injectables companies are also growing significantly due to the extensive use of generic injectables in the treatment of a wide range of chronic diseases while providing the same efficacy and safety as the reference injectables.
Discover the top commercial dose pharmaceutical injectables companies in contract manufacturing
Our team at Pharmaceutical Technology has researched and listed some of the leading contract manufacturers of commercial dose injectables.
All our information is based on our industry intel, valuable company insights, and decades of experience in the sector.
Our extensive list includes providers of various services and solutions including, but not limited to:
- Hypodermal injection needles
- Cartridge-based injections
- Solubiliser and emulsifier agents
- Type II premium injection vials, and ampoules
- Implanters
- Dry injections
Our rigorously researched and professionally written download document contains a wealth of industry-specific information.
This content will be of particular interest and value to process development managers, production assistants, injectable device development managers, validation officers and any other individual involved in drug injectables manufacturing.
Our download document also contains some highly detailed information on the suppliers and their product offerings, alongside contact details where required.
Primary factors driving the demand for injectables
Rapid absorption, faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are driving the demand for injectable commercial doses.
Injectables pharmaceutical companies are gaining traction for providing manufacturing support for monoclonal antibody therapies, large molecule injectable drugs, and drugs treating infectious diseases.
Factors include things such as the growing prevalence of chronic diseases, shorter and cheaper research and development (R&D) cycles of generic injectables.
In addition, there is now a growing global focus on the treatment of rare diseases, which is boosting the growth of generic injectables companies in the global market.
Delivery innovations by leading injectables pharmaceutical companies
Injectables are focusing on improving user convenience and patient friendliness of injectable drugs by using innovative packaging and delivery systems.
Prefilled syringes that are user-friendly and enable patients to self-administer the drug from the comfort of their homes are becoming increasingly popular.
Pens, autoinjectors and infusion pumps are other packaging forms for injectable drugs that are easy to handle and facilitate long-term administration.
Furthermore, connected autoinjectors and infusion pumps are emerging that feature data capture and reporting capabilities.
Wearable forms of injectable drugs such as clip-on and stick-on parenteral delivery systems are also convenient and can fit discreetly into clothing.
FAQs
What are injectables, and why are they important in pharmaceutical treatment?
Injectables are medications delivered directly into the body via needle or syringe, offering rapid absorption and faster therapeutic action compared to oral medications.
They are essential for treating chronic diseases, delivering biologics, and administering vaccines.
Injectables bypass the digestive system, ensuring that drugs are not broken down by stomach acids and are available in their active form for immediate effect.
What are the different types of pharmaceutical injectables?
Pharmaceutical injectables come in various forms, including intravenous (IV) injections, intramuscular (IM) injections, and subcutaneous (SC) injections.
IV injections are used for rapid drug delivery into the bloodstream, while IM and SC injections offer slower absorption, making them suitable for sustained-release therapies.
Prefilled syringes, autoinjectors, and cartridge-based injectables are other common forms.
How are generic injectables impacting the pharmaceutical industry?
Generic injectables offer cost-effective alternatives to brand-name drugs while maintaining the same efficacy and safety.
The demand for these products is growing as healthcare providers seek to reduce treatment costs for chronic illnesses.
Generic injectables undergo stringent regulatory review to ensure they meet the same standards as their branded counterparts, making them a trusted option in global healthcare.
How is contract manufacturing supporting the injectable pharmaceutical sector?
Contract manufacturing organizations (CMOs) provide essential services for the production of injectables, particularly for companies that lack in-house capabilities.
CMOs offer expertise in sterile manufacturing, scale-up from clinical trials to commercial production, and compliance with regulatory standards.
This allows pharmaceutical companies to focus on research and development while outsourcing the complexities of injectable production.
What innovations are shaping the future of injectable drug delivery?
Innovations in injectable drug delivery include wearable injectors, connected autoinjectors, and smart devices that track dosage and patient compliance.
Prefilled syringes and needle-free injection systems are also improving user convenience and reducing the risk of contamination.
These advancements aim to enhance patient experience, particularly for individuals who require long-term injectable therapies.